Theravance
Junning Lee is the Founder and CEO of Lexenpharm since March 2017, and has served as the Senior Vice President of Technical Operations at Theravance Biopharma and Theravance since September 2014 and January 2014, respectively. Junning Lee holds a Ph.D. in Chemistry from Boston University, where studies were completed from 1984 to 1989.
This person is not in any teams
This person is not in any offices